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Familial typical migraine is a common, complex disorder that shows strong familial aggregation. Using latent-class
analysis (LCA), we identified subgroups of people with migraine/severe headache in a community sample of 12,245
Australian twins (60% female), drawn from two cohorts of individuals aged 23–90 years who completed an interview
based on International Headache Society criteria. We report results from genomewide linkage analyses involving
756 twin families containing a total of 790 independent sib pairs (130 affected concordant, 324 discordant, and
336 unaffected concordant for LCA-derived migraine). Quantitative-trait linkage analysis produced evidence of
significant linkage on chromosome 5q21 and suggestive linkage on chromosomes 8, 10, and 13. In addition, we
replicated previously reported typical-migraine susceptibility loci on chromosomes 6p12.2-p21.1 and 1q21-q23,
the latter being within 3 cM of the rare autosomal dominant familial hemiplegic migraine gene (ATP1A2), a finding
which potentially implicates ATP1A2 in familial typical migraine for the first time. Linkage analyses of individual
migraine symptoms for our six most interesting chromosomes provide tantalizing hints of the phenotypic and
genetic complexity of migraine. Specifically, the chromosome 1 locus is most associated with phonophobia; the
chromosome 5 peak is predominantly associated with pulsating headache; the chromosome 6 locus is associated
with activity-prohibiting headache and photophobia; the chromosome 8 locus is associated with nausea/vomiting
and moderate/severe headache; the chromosome 10 peak is most associated with phonophobia and photophobia;
and the chromosome 13 peak is completely due to association with photophobia. These results will prove to be
invaluable in the design and analysis of future linkage and linkage disequilibrium studies of migraine.
The classification of migraine has been impeded by the
lack of pathognomonic markers, the co-occurrence of
migraine subtypes and of migraine and tension-type
headache within a single individual, and disputes over
the validity of inclusion criteria and the boundaries be-
tween migraine and other headache subtypes (Merikan-
gas et al. 1993, 1994). The two major subtypes of mi-
graine defined by International Headache Society (IHS)
criteria (Headache Classification Committee of the In-
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ternational Headache Society 1988), migraine without
aura (MO) and migraine with aura (MA), frequently co-
occur. A recent study found that 42% of individuals with
active migraine with aura also reported having migraine
attacks with no aura (Launer et al. 1999). Moreover,
MO and MA frequently coexist within the same family;
a headache center in Italy reported that 45% of families
with MA also had members with MO (Mochi et al.
1993). The co-occurrence of the rare but severe familial
hemiplegic form of migraine (FHM) and migraine with
and without aura within families has also been reported
(Joutel et al. 1994; Ophoff et al. 1994). Furthermore,
changes in the presenting symptoms of migraine attacks,
from hemiplegic to severe headache with or without aura
in later life (Ophoff et al. 1994), as well as the devel-
opment of aura among subjects with MO and the con-
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verse (Ophoff et al. 1994; Kallela et al. 2001), suggest
overlapping etiology.
No study performed to date has led to the identifi-
cation of a gene responsible for typical migraine. A gene
on 19p13 has been identified for FHM1 (MIM 141500),
a rare autosomal dominant subtype of migraine (Joutel
et al. 1993; Ophoff et al. 1996). Mutations in this gene,
CACNA1A (MIM 601011), a brain-specific P/Q-type
calcium-channel gene, account for only a small fraction
of all patients with migraine and for 50% of families
with the FHM subtype (Ducros et al. 2001). Another
20% of families with FHM show linkage to 1q21-31
(FHM2 [MIM 602481] and FHM3 [MIM 607516])
(Ducros et al. 1997; Gardner et al. 1997). In a recent
breakthrough, missense mutations in a chromosome
1q23 gene, ATP1A2 (MIM 182340), which encodes a
Na, K-ATPase, were identified in four distinct pedi-
grees with FHM (De Fusco et al. 2003; Vanmolkot et
al. 2003).
Several studies have suggested that the 19p13
CACNA1A locus may also be involved in nonhemi-
plegic migraine (MGR5 [MIM 607508]) (May et al.
1995; Ophoff et al. 1997; Nyholt et al. 1998b; Terwindt
et al. 2001), although contradictory data have also been
reported (Hovatta et al. 1994; Jones et al. 2001). Re-
cently, loci at 1q31 (MGR6 [MIM 607516]) (Lea et al.
2002), Xq (MGR2 [MIM 300125]) (Nyholt et al. 1998a,
2000; Oterino et al. 2001), and 15q11-q13 (MGR7
[MIM 609179]) (Russo et al. 2005) have been impli-
cated in typical familial migraine. In addition, a number
of association studies have shown linkage and/or linkage
disequilibrium between various gene loci and either MA
or MO (Pardo et al. 1995; Peroutka et al. 1997; Del
Zompo et al. 1998; Ogilvie et al. 1998; Kowa et al.
2000; Lea et al. 2000; Paterna et al. 2000; McCarthy
et al. 2001; Tzourio et al. 2001; Yilmaz et al. 2001;
Rainero et al. 2002; Trabace et al. 2002; Kusumi et al.
2003; Mochi et al. 2003; Colson et al. 2004, 2005).
Unfortunately, most of these studies have remained sin-
gle reports and await confirmatory replication studies
or have been contradicted by studies done by other
groups.
The first genomewide linkage screen for typical fa-
milial MA genes was conducted by a group in Helsinki
(Wessman et al. 2002). They studied a sample of 50
Finnish families (comprising 252 individuals with MA)
and found significant evidence for linkage on 4q24
(MGR1 [MIM 157300]). Interestingly, a genomewide
scan in Iceland of 289 patients with MO also showed
significant linkage to the chromosome 4q region (Bjorns-
son et al. 2003), further supporting the existence of trait
loci common to both major IHS classes of migraine.
Three additional published genomewide screens have
identified several new loci, with significant linkage on
6p12.2-p21.1 (MGR3 [MIM 607498]) (Carlsson et al.
2002), 11q24 (Cader et al. 2003), and 14q21.2-q22.3
(MGR4 [MIM 607501]) (Soragna et al. 2003), sug-
gesting additional migraine genes in these regions.
Hence, there is a growing body of evidence supporting
the existence of both phenotypic and genetic hetero-
geneity, with multiple genes contributing to migraine
susceptibility.
To diagnose migrainous headache more accurately
and to examine whether MO and MA are two separate
entities or not, we recently performed latent-class anal-
ysis (LCA)—a statistical method best characterized as a
categorical analog of factor analysis for finding sub-
types of related cases (latent classes) from multivariate
categorical data (Rindskopf and Rindskopf 1986)—to
investigate the presence and composition of migraine
symptom subgroups in our twin sample (Nyholt et al.
2004).
Migraine data were obtained during the course of an
extensive, semistructured telephone interview that in-
cluded diagnostic assessments of migraine. Participants
answering “yes” to the question of whether they have
ever had migraine or recurrent attacks of headache then
answered a number of questions, relating to their head-
aches, that were developed by an experienced migraine
researcher (K.R.M.) on the basis of IHS diagnostic cri-
teria (tables 1 and 2). The interview yielded diagnoses
for MO and MA, with the use of visual prodromal symp-
toms as an index of MA.
In our younger cohort of twins born in 1964–1971
(3,438 females and 2,774 males), the use of IHS di-
agnostic criteria yielded an MO prevalence of 15.3%
(20.4% female; 9.0% male), which is comparable to that
found in other large epidemiologic studies in similar
Western populations (Stewart et al. 1992), including a
recent population-based Australian study (the Blue
Mountains Eye Study [ ]) that found that 22%np 3,654
of women and 9.6% of men satisfied the IHS criteria
for MO (Wang et al. 1997). The total same-sex DZ
relative risks (RRs)—applicable to first-degree relatives
in the general population—associated with the IHS
groups were surprisingly similar, with an RR of 1.53
(95% CI 0.61–3.83) for MO-MO and 1.77 (95% CI
1.00–3.13) for MA-MA (Nyholt et al. 2004).
LCA, performed using the Latent GOLD 2.0 package
(Statistical Innovations), identified one asymptomatic
class (CL0) and three major symptomatic classes (fig. 1),
representing a mild form of recurrent nonmigrainous
headache (CL1); a moderately severe form of migraine,
typically without visual aura, loading (i.e., had endorse-
ment probability0.5) on all IHS MO symptoms except
unilateral location and nausea/vomiting (CL2); and a
severe form of migraine, typically with visual aura, load-
ing on all IHS symptoms (CL3). Of particular impor-
tance is that although aura was often associated with
other and more severe neurological symptoms and was
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Table 1
IHS Diagnostic Criteria for MO
Criteria for MO
A. At least five attacks fulfilling B through D
B. Headache lasting 4–72 h (untreated or unsuccessfully treated)
C. Headache has at least two of the following characteristics:
1. Unilateral location
2. Pulsating quality
3. Moderate/severe (a) or prohibitive (b) intensity (inhibits or
prohibits daily activities)
4. Aggravation by walking stairs or by similar routine physi-
cal activities
D. During headache at least one of the following is present:
1. Nausea and/or vomiting
2. Photophobia (a) and phonophobia (b)
NOTE.—Excerpted from IHS classification of headache (Head-
ache Classification Committee of the International Headache So-
ciety 1988).
Table 2
The 10 Symptom Response Variables Based on IHS Diagnostic
Criteria
Abbreviation
for Variable Codea Description
15 Episodes A At least five migraines/episodes of
headache during lifetime
4–72 h B Average typical migraine/headache
lasts between 4 and 72 h
Unilateral C1 Headache usually occurs on one
side of the head
Pulsating C2 Usual headache pain is described
as throbbing, pulsating, or
pounding
Moderate/severe C3a Pain associated with headache is
described as moderate or severe
Prohibitive C3b Headaches inhibit or prohibit daily
activities
Nausea/vomiting D1 Associated and recurrent attacks
of nausea, vomiting, or diarrhea
Photophobia D2a Enhanced sensitivity to light
Phonophobia D2b Enhanced sensitivity to noise
Aura … Associated and recurrent visual
problems such as blurring,
showers of light, blind spots, or
double vision
a Codes correspond to the outline of diagnostic criteria in table 1.
predominantly found in latent class CL3, almost one
quarter of CL3 individuals did not report aura. Fur-
thermore, aura was present in 39.3% of individuals in
CL2. Therefore, the LCA did not specifically separate
MO from MA. Instead, the LCA classifications are based
on the severity and combination of symptoms and do
not support the hypothesis that MO and MA are sep-
arate subtypes. Moreover, both traditional (principal
components) factor analysis using SPSS and latent factor
analysis using Latent GOLD indicated that a single ma-
jor factor best fit the data, supporting the existence of
a severity continuum from mild to severe headache, of
which the LCA classes and IHS classes MO and MA are
a part. In other words, an individual’s liability to mi-
graine is of a single dimension representing the contri-
bution of all genetic and environmental influences; in-
dividuals whose liability exceeds a certain threshold
manifest the disorder, with the more severely affected
individuals assumed to have a higher liability than the
less severely affected individuals. Also consistent with
the threshold model is that three times as many females
than males had migraine; thresholds for females were
significantly lower than those for males. Therefore, in
searching for predisposing genes, we should expect to
find some trait loci common to both major classes of
IHS migraine, with perhaps additional loci, or more-
severe alleles, associated with more-severe types, such as
MA or CL3 (Nyholt et al. 2004).
We classified 407 individual twins (203 female [5.9%
of total female sample]; 204 male [7.4% of total male
sample]) in CL1, 1,267 twins (781 [22.7%] female; 486
[17.5%] male) in CL2, and 991 twins (793 [23.1%]
female; 198 [7.1%] male) in CL3. Therefore, the prev-
alence of migrainous headache identified by LCA clas-
sification (hereafter, “LCA migraine,” which represents
CL2 and CL3) was 36.5% (45.8% female; 24.7%
male). Using the total same-sex data, the relative risks
associated with the LCA groups were 1.40 (95% CI
1.03–1.90) for CL2-CL2 and 2.18 (95% CI 1.57–
3.03) for CL3-CL3 (Nyholt et al. 2004). Importantly,
these data did not support the presence of genetic sex-
specific effects (i.e., effects expressed in one sex but not
in the other) or significant sex differences in the mag-
nitude of genetic influences (i.e., sex limitation) on risk
of migraine.
The ability of LCA to weight each symptom by use
of endorsement frequencies and to obtain for each symp-
tom response profile the associated posterior class-mem-
bership probability allowed more individuals to be clas-
sified (table 3). That is, although the LCA and IHS
classifications were highly correlated (Spearman’s cor-
relationp 0.97), 1,305 individuals whose condition did
not satisfy IHS criteria were considered to be affected
under the LCA classification (i.e., were in CL2 or CL3).
Importantly, the heritability (h2) estimate (by use of
structural equation modeling) in our sample under the
four-group LCA scheme was 0.40 (95% CI 0.29–0.46),
compared with 0.36 (95% CI 0.22–0.42) under the IHS
scheme.
A slight increase in heritability was observed after the
individuals who screened negative [CL0] were grouped
with the latent class CL1, producing a heritability esti-
mate of 0.43 (95% CI 0.29–0.50). This strategy makes
sense conceptually, since, although we would not expect
individuals who screen negative for “migraine or recur-
rent attacks of headache” to experience diagnostic cri-
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Table 3




Negative Positive MO MA
CL0 3,547 … … …
CL1 … 407 … …
CL2 … 1,010 182 75
CL3 … 295 173 523
NOTE.—“Negative” and “Positive” denote
“No” and “Yes” responses to the screening ques-
tion “Have you ever had migraine or recurrent
attacks of headache?” Consequently, individuals
who answered “No” gave no symptom data.
Figure 1 Profile plot for the three symptomatic classes (CL1, CL2, and CL3) under the four-class model. Endorsement probabilities
indicate the proportion of individuals in each class presenting with each symptom. All endorsement probabilities for CL0 were !0.005 (data
not shown). Descriptions of symptom abbreviations are given in table 2.
teria sufficient for inclusion in CL2/CL3, they may ex-
perience enough symptoms sufficient for inclusion in
CL1. Moreover, the precision of the heritability estimate
for the three-group LCA scheme remains similar to that
for the four-group LCA scheme, which suggests no loss
of genetic information.
In contrast, the grouping of individuals who screened
negative with those who screened positive, produced a
heritability estimate of 0.31 (95% CI 0–0.41) and a de-
crease in the precision of the heritability estimate (as
reflected in the expanded CI), compared with the four-
group IHS scheme. This suggests a poorer correspon-
dence between genetic risk and IHS grouping.
Higher heritability was still observed for the LCA
scheme ( ; 95% CI 0.23–0.49), compared with2h p 0.41
the IHS scheme ( ; 95% CI 0.05–0.44), when2h p 0.33
a clinically relevant “unaffected-affected” dichotomy
was used. We therefore hypothesized that use of our
LCA-based diagnostic scheme would provide consider-
ably more power than use of the IHS criteria to identify
genes underlying migraine susceptibility (Nyholt et al.
2004).
The present linkage study used an LCA-derived mi-
graine sample comprising two cohorts drawn from the
Australian Twin Registry. In 1993–1995, a telephone
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Figure 2 Results of SOLAR genomewide multipoint linkage analysis for LCA migraine, showing thresholds for nominal Pp .01
(dash-dot-dot line) and (dotted line).Pp .05
interview that included a diagnostic assessment of psy-
chiatric disorders, including alcohol use and abuse, anx-
iety, depression, and phobias, was administered to an
older cohort of twins, born in 1902–1964. A total of
5,996 individual twins completed the 1993–1995 inter-
view (Heath et al. 1997). Between 1996 and 2000, a
younger cohort of twins (born in 1961–1975) under-
went a similar extensive semistructured telephone inter-
view, designed to assess physical, psychological, and so-
cial manifestations of alcoholism and related disorders
(Heath et al. 2001); 6,265 individual twins completed
the interview. Both cohort samples were unselected with
regard to personal or family history of alcoholism or
other psychiatric or medical disorders. Migraine symp-
tom data were obtained in the course of the telephone
interviews. For the combined sample, the mean age at
interview was years (range 23–90 years).37.5 11.3
Although the wording of the questions was identical for
both cohorts, the younger cohort was asked questions
relating to all 10 symptoms in tables 1 and 2, whereas
the older cohort were not asked questions relating to
having at least five migraine/episodes of headache during
lifetime (“15 episodes”), average typical migraine/head-
ache lasting between 4 and 72 h (“4–72 h”), and pain
associated with headache described as moderate or se-
vere (“moderate/severe”).
The younger and older cohort data were combined,
thus allowing the LCA to impute class membership in
the older cohort on the basis of the pattern of all 10
symptoms observed in the younger cohort. To examine
the accuracy of imputed class memberships, we com-
pared the classification results for the younger data set
using all 10 available IHS symptoms with the classifi-
cation results for the younger data set using only the 7
IHS symptoms that were available for the older cohort.
Compared with analyses using all 10 symptoms, anal-
yses using only 7 symptoms correctly classified 98.5%
and 96.0% of individuals as unaffected and affected,
respectively, which indicates that the three missing symp-
toms in the older cohort would have negligible effect on
the accuracy of individual LCA migraine diagnoses.
LCA of the combined younger and older data set
(12,245 individuals) identified 494 concordant affected
DZ twin pairs (152 CL2-CL2, 217 CL2-CL3, and 125
CL3-CL3), 228 extreme discordant DZ twin pairs (CL0/
1-CL3), and 194 extreme concordant MZ twin pairs
(CL3-CL3) for LCA migraine.
The current study included linkage analysis using LCA
migraine diagnoses and genotypic data from a compi-
lation of four smaller genome scans performed for other
studies at the Queensland Institute of Medical Research.
Genotyping for the four scans was done at Gemini Gen-
omics (426 microsatellite markers), Sequana Therapeu-
tics (519 markers), the Center for Mammalian Genetics
Reports 505
Table 4














1 160 1.16 159 1.53 D1S1679 159.92
5 115 3.03 115 3.70a D5S2501 116.63
6 101 1.02 102 1.22 D6S1056 100.55
8 98 1.22 97 1.77b D8S270 97.85
10 98 2.13 97 2.32b D10S2327 98.72
13 56 1.52 56 1.63b D13S1807 56.15
a Satisfies accepted criteria for genomewide significant linkage (Lander and Kruglyak 1995).
b Satisfies accepted criteria for genomewide suggestive linkage (Lander and Kruglyak 1995).
at the Marshfield Clinic Research Foundation (776
markers), and the University of Leiden (435 markers).
Recruitment of participants for these studies was pri-
marily based on participant involvement in previous
phenotype collection studies. There was considerable
overlap between the participants in the four studies and
in the four marker sets used (see below). As a result,
genotypic data for a subset of the younger and older
cohorts was available. DNA collection, genotyping, and
data-cleaning methods are discussed in brief below and
in more detail elsewhere (Zhu et al. 2004; B. K. Cornes,
S. E. Medland, K. I. Morley, M. A. R. Ferriera, S. Gor-
don, G. Zhu, D. L. Duffy, M. Campbell, H. Beeby, G.
W. Montgomery, A. J. Birley, and N. G. Martin, un-
published data).
Pedigree structures for each scan were examined using
Graphic Representation of Relationships (GRR) (Abe-
casis et al. 2001) and RELPAIR (Epstein et al. 2000;
Duren et al. 2003), to identify inconsistencies between
the genotypic data and pedigree relationships. Once any
discrepancies were resolved, data for the four scans were
merged and then checked again for pedigree errors by
GRR and for Mendelian inconsistencies by SIB-PAIR
(Duffy 2002). The combined genome scan data included
458 markers that were typed in two or more scans,
which were included separately on the genetic map for
the scan, separated by a very small distance (0.001 cM).
The consistency of genotype information between these
458 markers was checked via cross-tabulations of allele
calls between different scans. Markers with genotypic
data inconsistent between different genome scans were
removed from further analysis. Unlikely genotypes were
identified and wiped using MERLIN (Abecasis et al.
2002). GENEHUNTER (Kruglyak et al. 1996) and
MENDEL (Lange et al. 1988) were used to identify and
examine potential map errors. Map positions were in
Kosambi cM, estimated via locally weighted linear re-
gression from the NCBI build 34.3 physical map posi-
tions and from published deCODE and Marshfield ge-
netic map positions (Kong et al. 2004). Where the results
suggested inconsistencies between genetic map distances
and recombination fractions, the primer sequences for
all markers in the region were blasted against the entire
human genome sequence (Ensembl NCBI build 34.3).
The genetic map was then revised to include the updated
physical positions of all markers in problematic regions,
with new map distances interpolated as above.
With the use of the revised map, the original genotype
data (with inconsistent duplicated markers removed)
were cleaned of unlikely genotypes by use of MERLIN,
and map errors were resolved using GENEHUNTER.
The cleaned genome-scan data included 1,881 markers,
of which 422 were duplicates, leaving a total of 1,459
unique markers. The combined genome scan included a
total of 5,199 individuals from 1,593 families.
Of the total 1,593 families for whom migraine symp-
tom data were available, 426 families contained at least
one affected (CL2/CL3) concordant or one discordant
nonidentical-twin or sibling pair, 330 families contained
one unaffected concordant sib pair, and the remaining
families were uninformative for linkage (i.e., had !2 ge-
notyped children for whom LCA migraine diagnoses
were available). These 756 families contained 556 af-
fected and 988 unaffected individuals. With allowance
for nonindependence among sib pairs derived from the
same sibship (i.e., a sibship of size S being equivalent to
independent sib pairs [Suarez and Hodge 1979]),S 1
the 756 families informative for linkage to LCA mi-
graine contained 790 independent sib pairs (130 af-
fected concordant, 324 discordant, and 336 unaffected
concordant).
For the linkage analyses, allele frequencies for marker
loci were estimated from the founders across all 1,593
families by use of PEDMANAGER software (available
online; see Web Resources). Autosomal linkage data
were analyzed using the latest available versions of SO-
LAR (v2.1.4) (Almasy and Blangero 1998) and MER-
LIN-regress (v0.10.1) (Abecasis et al. 2002; Sham et al.
2002) analysis packages.
SOLAR uses a liability-threshold model within a var-
iance-components (VC) framework to perform linkage
analysis for a dichotomous trait (Duggirala et al. 1997).
Briefly, the threshold model assumes a latent continuous
variable (“liability”) underlying a categorical trait. The
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Figure 3 Results of MERLIN-regress genomewide multipoint linkage analysis for LCA migraine, showing thresholds obtained via sim-
ulation for significant linkage (dashed line) and suggestive linkage (dash-dot line). Thresholds estimated via linear regression for nominal
(dash-dot-dot line) and (dotted line) are also displayed.Pp .01 Pp .05
threshold can be regarded as the z value of the normal
distribution that divides the area under the curve in such
a way that it gives the correct proportion of individuals
in each (diagnostic) group, thus reflecting the prevalence
of each group (Neale and Cardon 1992). The tetrachoric
correlation, also termed “correlation of liability,” as-
sumes that underlying the observed dichotomous distri-
bution of affection status is a continuous, normally dis-
tributed latent liability (Kendler 1993). That is, the
tetrachoric correlation is an estimate of the correlation
between two latent variables, where each latent variable
is assumed to have a bivariate normal distribution. SO-
LAR LOD scores obtained via this approach do not
require specification of a penetrance model and are as-
ymptotically distributed the same way as standard LOD
scores. Hence, nominal pointwise thresholds of Pp
and are equivalent to SOLAR LOD scores.01 Pp .05
of 1.18 and 0.59, respectively (Nyholt 2000).
In addition to the SOLAR liability threshold model,
the “model-specification-free” MERLIN-regress statistic
was chosen because it has been shown to be comparable
in power to the most powerful QTL linkage approach
(i.e., VC) while being more robust to non–normally dis-
tributed trait values (Sham et al. 2002). Furthermore,
the computationally simple MERLIN-regress statistic is
ideally suited for empirical analyses (e.g., gene-dropping
simulations) to obtain sample-specific significance levels.
Indeed, multipoint analysis of our observed genomewide
linkage data with SOLAR took ∼3.5 h on our Linux
server, whereas it took a little less than 5 min with MER-
LIN-regress.
Affected individuals (CL2/CL3) were given a trait
value of 1, and unaffected individuals (CL0/CL1) were
given a value of 0. The validity of this, and indeed that
of the original regression Haseman-Elston approach
(Haseman and Elston 1972) for binary traits, has been
pointed out numerous times (Elston et al. 2005).
To obtain empirical estimates of genomewide signif-
icance levels, simulations were performed using the ped-
igree structures in the data set and the observed patterns
of genotyping, including any missing genotypes. These
simulations allowed us to take account of uneven marker
spacing and informativeness (see the work of Sawcer et
al. [1997] and Kruglyak and Daly [1998] for a discus-
sion of the utility of empirical significance levels in link-
age analysis) and to calculate the probability of observ-
ing one or more peaks of a certain height (Wiltshire et
al. 2002). Data for 5,000 simulated genome scans were
generated using MERLIN-regress under the assumption
that there were no susceptibility loci; each replicate was
analyzed in the same way as the observed data, and the
highest peak for each chromosome was recorded. The
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Figure 4 Results of MERLIN-regress chromosome-specific multipoint linkage analysis for LCA migraine and subphenotypes reaching
nominal .P  .05
empirical significance level of an observed LOD score
was then estimated by counting the proportion of ge-
nome scans containing one or more peaks of that size.
The cut-off for suggestive linkage (MERLIN-regress
) was calculated as the LOD score that wasLODp 1.62
observed on average once per genome scan (i.e., 5,000
times across the 5,000 replicates, or the 5,000th highest
LOD score), thus representing the average maximum
peak size expected once per genome scan by chance
alone (Lander and Kruglyak 1995). The significant link-
age threshold (MERLIN-regress ) was de-LODp 2.99
fined as the score occurring with probability 0.05 in a
genome scan (Lander and Kruglyak 1995) (i.e., 250
peaks of equal or greater size observed across the 5,000
simulations, or the 250th highest LOD score). For con-
firmation (replication) of previously reported significant
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linkage findings, a nominal P value of .01 was used
(Lander and Kruglyak 1995). We also included LOD
score thresholds for nominal to assist compar-Pp .05
ison with previous and future linkage studies, as rec-
ommended by Lander and Kruglyak (1995).
SOLAR multipoint LOD scores (by use of exact mul-
tipoint identity by descent [IBD] values obtained from
MERLIN) calculated at 1-cM increments are presented
in figure 2. The highest LOD score (table 4) was obtained
on chromosome 5 at 115 cM from the pter (LODp
; asymptotic pointwise ). The next53.03 Pp 9.37# 10
highest LODs were found on chromosome 10 at 98 cM
( ; ), chromosome 13 at 564LODp 2.13 Pp 8.68# 10
cM ( ; ), chromosome 8 at 98 cMLODp 1.52 Pp .0041
( ; ), chromosome 1 at 160 cMLODp 1.22 Pp .0089
( ; ), and chromosome 6 at 101LODp 1.16 Pp .010
cM ( ; ). No other regions pro-LODp 1.02 Pp .015
duced LOD scores 11.
MERLIN-regress multipoint LOD scores calculated at
1-cM increments are presented in figure 3. The highest
LOD score (table 4) was again obtained on chromosome
5 at 115 cM from the pter ( ). The nextLODp 3.70
highest LODs were found on chromosome 10 at 97 cM
( ), chromosome 8 at 97 cM (LODp 1.77),LODp 2.32
chromosome 13 at 56 cM ( ), chromosomeLODp 1.63
1 at 159 cM ( ), and chromosome 6 at 102LODp 1.53
cM ( ). As can be seen by comparing fig-LODp 1.22
ures 2 and 3, the SOLAR and MERLIN-regress LOD
scores were highly correlated ( ). The resultingrp 0.99
simple linear regression equation (1.1509# SOLAR
-regress LOD) is an excel-LOD 0.0015pMERLIN
lent predictor of small-to-moderate values. This equa-
tion estimated that the nominal andPp .01 Pp .05
SOLAR LOD scores of 1.18 and 0.59 are equivalent
to MERLIN-regress LOD scores of 1.35 and 0.68,
respectively.
The MERLIN-regress LOD scores were slightly higher
than the SOLAR VC LOD scores. This increase could
be explained by the fact that the regression test has been
shown to be more powerful than VC in sibships of size
3. Alternatively, the regression test has been shown to
produce a slightly inflated type I error rate for a non–
normally distributed trait in combination with incom-
plete (!100%) IBD information (Sham et al. 2002).
Given that our sample contained 24 sibships of size 3
and 5 sibships of size 4 and that our trait was clearly
not normally distributed, the increase in MERLIN-re-
gress LOD scores may be the result of either of these
two explanations or a combination of both. It was
therefore important to verify MERLIN-regress signifi-
cance levels by Monte Carlo methods (i.e., gene-drop-
ping simulations).
Results of our 5,000 simulations indicated that the
chromosome 5 peak easily surpasses our threshold for
significant linkage, with only 56 peaks 3.70 observed
(genomewide ). The chromosome 10 peak isPp .0112
highly suggestive of linkage, with only 1,106 peaks
2.78 observed. The chromosome 8 and chromosome
13 peaks also surpass our suggestive threshold, with
3,606 peaks 1.77 and 4,996 peaks 1.63 observed,
respectively, whereas chromosome 1 and chromosome 6
peaks fall short of our suggestive threshold with 6,275
peaks 1.53 and 11,984 peaks 1.22 observed, re-
spectively. Given that these simulations indicate, on av-
erage, only one LOD 1.63 and that ∼1.3 LODs1.53
and 2.4 LODs 1.22 are expected by chance, our data
suggest the presence of multiple loci contributing to mi-
grainous headache.
Whereas the chromosome 5, 8, and 10 loci are novel,
the chromosome 6 region (major peak SOLAR LOD of
1.02 [ ] at 101 cM; secondary peak LOD ofPp .015
0.85 [ ] at 71 cM) overlaps the 6p12.2-p21.1Pp .024
(67.45–77.42 cM) critical region previously reported for
a large Swedish family with 30 individuals who have
MO or MA, spanning four generations (MGR3 [MIM
607498]) (Carlsson et al. 2002), which adds support to
the presence of a QTL in this region. An even more
interesting finding concerns the chromosome 1 peak at
159 cM, since it is within 3 cM of the FHM-implicated
ATP1A2 gene (De Fusco et al. 2003; Vanmolkot et al.
2003), thus potentially implicating ATP1A2 in familial
typical migraine for the first time. We did not find any
support for linkage at other previously reported loci.
To investigate the effect of collapsing the CL2 and
CL3 classes into one affection class, we reanalyzed our
genomewide linkage data using a three-category phe-
notype CL0/1, CL2, and CL3. MERLIN multipoint
LOD scores for this trichotomous phenotype were re-
markably similar to the LOD scores obtained for our
primary dichotomous LCA migraine phenotype (data
not shown). Therefore, as indicated by our previous her-
itability analyses, our dichotomous LCA migraine phe-
notype provides a stable and accurate correspondence
between genetic risk and migrainous headache.
During our work on the classification and genetic ep-
idemiology of migraine and its symptoms, genetic anal-
ysis of questionnaire data revealed that the answer to
our screening question and each of the 10 IHS symptoms
are heritable ( ). To see whether certain2h p 0.35–0.39
symptoms are more associated with our linkage peaks,
we performed linkage analyses for LCA migraine con-
ditional on each individual symptom (i.e., for each symp-
tom, affected individuals must have both the individual
symptom and LCA migraine). Figure 4 shows MERLIN-
regress multipoint LOD scores for LCA migraine and
individual IHS symptoms, with pointwise forP  .05
our six most interesting chromosomes.
The subphenotype analyses clearly indicate that in-
dividual symptoms are differentially associated with par-
ticular linkage peaks in our data. Specifically, 5 of the
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10 IHS symptoms produced nominally significant LOD
scores at the chromosome 1 locus, with “nausea/vom-
iting” and “phonophobia” being the symptoms most
associated. The chromosome 5 region probably contains
a general migrainous headache gene, with all 10 IHS
symptoms producing LOD scores with . In fact,P  .05
although strict IHS diagnoses could only be determined
for the younger cohort (because the older cohort was
not asked questions relating to “15 episodes,” “4–72
h,” and “moderate/severe”), a LOD of 1.76 was still
obtained on chromosome 5 for IHS MO. The chro-
mosome 6 locus is associated with six of the IHS symp-
toms, especially “prohibitive” and “photophobia.” The
chromosome 8 locus is also associated with six IHS
symptoms, in particular “nausea/vomiting” and “mod-
erate/severe.” Finally, 7 of the 10 symptoms, plus IHS
MO, are associated with the chromosome 10 locus,
whereas the chromosome 13 peak is completely due to
association with “photophobia.”
To further examine the relationship between individ-
ual symptoms and linkage to our six most interesting
chromosomes, we performed subphenotype analyses for
each symptom, in which affected individuals must sim-
ply have the individual symptom, regardless of LCA di-
agnosis (data not shown). These analyses further suggest
that individual symptoms may be associated with par-
ticular linkage peaks in our data. Specifically, the chro-
mosome 1 locus is most associated with “phonophobia”
( ); the chromosome 5 peak is predomi-LODp 1.79
nantly associated with “pulsating” ( ); theLODp 3.41
chromosome 6 locus is associated with “prohibitive”
( ) and “photophobia” ( ); theLODp 1.68 LODp 1.70
chromosome 8 locus is associated with “nausea/vom-
iting” ( ) and “moderate/severe” (LODpLODp 1.46
1.27); the chromosome 10 peak is most associated
with “phonophobia” ( ) and “photophobia”LODp 1.44
( ); and the chromosome 13 peak is com-LODp 1.63
pletely due to association with “photophobia” (LODp
1.55).
Although there is considerable correlation between
the symptoms (i.e., by application of the approach of
Cheverud [2001] and Nyholt [2004] to the subpheno-
type analyses conditioned on LCA migraine, the 10 IHS
symptoms are equivalent to analyzing ∼2.4 independent
phenotypes, whereas, for the IHS subphenotype analy-
ses, regardless of LCA migraine, the 10 symptoms are
equivalent to ∼5.7 independent phenotypes), we realize
that the subphenotype analyses described above provide
ample opportunity for false-positive results, given the
amount of multiple testing. Nevertheless, these explor-
atory results provide tantalizing hints of the phenotypic
and genetic complexity of migraine and will prove to be
invaluable in the design and analysis of our future link-
age and linkage disequilibrium studies. For example, we
shall stratify our future fine-mapping analyses according
to the individual symptoms associated with each impli-
cated genomic region.
Moreover, to aid the replication of previously iden-
tified potential susceptibility loci, we strongly advocate
that researchers analyze the individual symptoms of phe-
notypically complex traits such as migraine. By provid-
ing results from individual symptom analyses of impli-
cated regions, researchers may examine whether failure
to replicate a previous study’s finding may be the result
of genetic (locus) heterogeneity or differences in the sub-
phenotypic makeup of the individual samples.
Finally, given the higher diagnostic specificity, the
higher heritability, and the potential for larger sample
sizes in our LCA-based approach, we favor this approach
over a more restrictive IHS criteria–based classifica-
tion. Our ongoing collection of DNA and more-detailed
symptom data (which will allow strict IHS diagnosis of
MO and MA) from the aforementioned 916 families,
containing 494 DZ twin pairs concordant affected for
LCA migraine, 228 extreme discordant DZ twin pairs,
194 extreme concordant MZ twin pairs, and additional
siblings (86% mutually exclusive to the sample analyzed
here), will thus provide an invaluable resource for rep-
lication and further investigation of the relationship be-
tween previously reported migraine susceptibility gene
regions and individual migraine symptoms.
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